A Study of MK-0822 in Postmenopausal Women With Osteoporosis to Assess Fracture Risk (MK-0822-018)

Clinical trial NCT00529373 · TERMINATED

Trial details

NCT number: NCT00529373
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Postmenopausal Osteoporosis

Start date: 2007-09-13
Primary completion: 2012-11-14
Enrollment: 16071

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.